Baxter International (BAX)
23.50
-1.96 (-7.70%)
NYSE · Last Trade: Oct 30th, 12:19 AM EDT
Detailed Quote
| Previous Close | 25.46 |
|---|---|
| Open | 26.00 |
| Bid | 23.25 |
| Ask | 23.68 |
| Day's Range | 23.37 - 26.10 |
| 52 Week Range | 15.73 - 30.00 |
| Volume | 15,670,053 |
| Market Cap | 11.75B |
| PE Ratio (TTM) | -12.63 |
| EPS (TTM) | -1.9 |
| Dividend & Yield | 0.0400 (0.17%) |
| 1 Month Average Volume | 6,656,899 |
Chart
About Baxter International (BAX)
Baxter International is a healthcare company that focuses on developing and providing a wide range of medical products and services to enhance patient care. The company specializes in creating innovative therapies and solutions for various health conditions, including renal and hospital care. With a strong emphasis on sustainability and improving patient outcomes, Baxter manufactures essential medical devices, pharmaceuticals, and biotechnology products that support the treatment of chronic diseases and acute medical conditions. Their commitment to research and development drives advancements in healthcare technology, helping to meet the needs of healthcare professionals and patients worldwide. Read More
News & Press Releases
S&P 500 Top Movers: Oct. 29, 2026 Gainers and Loserschartmill.com
Via Chartmill · October 29, 2026
Revenue hit $3 billion with 5% organic growth; guidance raised on momentum.
Via The Motley Fool · October 29, 2026
S&P 500 Top Movers: Today's US Session Gainers and Loserschartmill.com
Via Chartmill · October 29, 2026
Healthcare company Baxter International (NYSE:BAX) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 5% year on year to $2...
Via StockStory · October 29, 2026
Baxter International Inc (NYSE:BAX) Breakout Setup Shows Technical Strengthchartmill.com
Via Chartmill · October 29, 2026
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2026.
By Baxter International Inc. · Via Business Wire · October 29, 2026
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results this Thursday before market hours. Here’s what you need to know. Baxte...
Via StockStory · October 27, 2026
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
Via StockStory · October 26, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
Via StockStory · October 23, 2026
S&P 500 Top Movers: EFX and HAS Lead Today's Gainers, GM and DVA Fallchartmill.com
Via Chartmill · October 20, 2026
What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 3.8% in the afternoon session after the U.S. Food and Drug Administration pu...
Via StockStory · October 20, 2026
S&P 500 Unusual Volume Movers for October 20chartmill.com
Via Chartmill · October 20, 2026
S&P 500 Top Movers: Gainers and Losers From Today's US Sessionchartmill.com
Via Chartmill · October 20, 2026
S&P 500 Gap-Down Stocks Fall in October 20, 2026 Sessionchartmill.com
Via Chartmill · October 20, 2026
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversifi...
Via StockStory · October 14, 2026
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/analyst/129835310?pwd=2FG2j7ZZ to pre-register for the call and receive the call information.
By Baxter International Inc. · Via Business Wire · October 7, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via StockStory · October 1, 2026
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes.
By Baxter International Inc. · Via Business Wire · September 30, 2026
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be...
Via StockStory · September 24, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · September 22, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
Via StockStory · September 1, 2026
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
Via StockStory · August 31, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via StockStory · August 21, 2026
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare equipment and supplies indu...
Via StockStory · August 19, 2026
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026.
By Baxter International Inc. · Via Business Wire · August 19, 2026